EUVIMEDEUVIMED entdecken
Crossref

MiR-484 promotes the malignant progression of glioma by inhibiting CDKN2A expression

Yingrui Gu, Hongbing Lei, Peipei Ma, Yi Chen

Folia Neuropathologica · 2023

DOI: 10.5114/fn.2023.130002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Neuropathologica, 2023. Verfasst von Yingrui Gu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of China Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: MicroRNAs, Glioma. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) is involved in glioma progression, but the specific molecular mechanism of CDKN2A in glioma cell migration and invasion needs to be further explored. MATERIAL AND METHODS: Data related to CDKN2A expression and glioma overall survival were obtained from The Cancer Genome Atlas (TCGA) database. Then, CDKN2A expression in glioma tissues/cells or paracancer tissues/astrocytes was measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR) or Western blot. Afterwards, Wound healing, Transwell and tube formation assay were performed to identify the invasion, migration and angiogenesis of glioma cells, respectively. TargetScan database predicted the targeted binding between miR-484 and CDKN2A, which was verified by dual luciferase reporter gene assay. Western blot and qRT-PCR were performed to detect the expression of VEGF, E-cadherin, N-cadherin and Vimentin in glioma cells. RESULTS: CDKN2A was low-expressed in glioma tissue/cells as compared to paracancer tissue/astrocytes, and was strongly associated to the poor prognosis of glioma. Further studies found that down-regulation of CDKN2A could promote migration, invasion and angiogenesis of glioma cells. Besides, miR-484 was high-expressed in glioma cells compared to astrocytes. Up-regulation of miR-484 could enhance migration, invasion and angiogenesis of glioma cells. In addition, up-regulated miR-484 suppressed the expression of E-cadherin, and promoted the expression of N-cadherin, Vimentin and VEGF. However, there was negative regulation of miR-484 and CDKN2A, and CDKN2A could partially offset the effect of miR-484. CONCLUSIONS: MiR-484 promoted cell migration, invasion and angiogenesis by inhibiting CDKN2A expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsGliomaHumansVimentinCell Line, TumorVascular Endothelial Growth Factor ACell ProliferationCadherinsGene Expression Regulation, NeoplasticCyclin-Dependent Kinase Inhibitor p16

Stichwörter der Autor:innen

angiogenesisgliomainvasionmiR-484migrationCDKN2A

Substanzen

MicroRNAsVimentinVascular Endothelial Growth Factor ACadherinsCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16MIRN484 microRNA, human

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital of China Naval Medical University, Shanghai, China.

Zitieren

APA

Gu, Y., Lei, H., Ma, P., & Chen, Y. (2023). MiR-484 promotes the malignant progression of glioma by inhibiting CDKN2A expression. Folia Neuropathologica. https://doi.org/10.5114/fn.2023.130002

Vancouver

Gu Y, Lei H, Ma P, Chen Y. MiR-484 promotes the malignant progression of glioma by inhibiting CDKN2A expression. Folia Neuropathologica. 2023. doi:10.5114/fn.2023.130002

BibTeX
@article{Gu2023,
  author = {Gu, Yingrui and Lei, Hongbing and Ma, Peipei and Chen, Yi},
  title = {MiR-484 promotes the malignant progression of glioma by inhibiting CDKN2A expression},
  journal = {Folia Neuropathologica},
  year = {2023},
  doi = {10.5114/fn.2023.130002}
}
Kostenlos starten →